Also, circulating levels of FGF-23 are associated with serum levels of several inflammatory markers in non-diabetic subjects with CKD [18], [19], and with circulating levels of TNFR1 in diabetic patients [20]. This evidence concerns the gene FGF23 and chronic kidney disease.